Clinical Trials
BioNTech Initiates Phase 1 Clinical Trial for Malaria Vaccine...
BioNTech SE announced the initiation of a first-in-human Phase 1 study with BNT165b1, the first candidate from the Company’s BNT165 program, to develop a multi-antigen...
Clinical Trials
Ceapro Inc. Receives Approval from Health Canada to Commence...
Ceapro Inc., a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, announced it has received approval...
Clinical Trials
New Zealand Health Groups Strive To Enhance Clinical Trials
Based on recommendations from an independent study report titled Enhancing Aotearoa New Zealand Clinical Trials, New Zealand's top health agencies will examine system-level adjustments to...
Clinical Trials
Canadian And US Pharma Firms To Test Psychedelic Drugs...
To take advantage of the UK's quick medication approval procedures, the North American psychedelic drug companies Mindset, PharmAla, Mydecine, and Psyence have inked a contract...
Clinical Trials
Immix Biopharma Announces Patient Dosing in Ongoing Phase 1b/2a...
Immix Biopharma, Inc, a biopharmaceutical company pioneering Tissue-Specific Therapeutics (TSTx)TM targeting oncology and immuno-dysregulated diseases, announced patient dosing in its ongoing Phase 1b/2a IMX-110 monotherapy...
Clinical Trials
By 2027, Market For Oligonucleotides Will Be Worth $16.7...
The growth in ongoing clinical trials for oligonucleotide-based therapies in important therapeutic fields like oncology is expected to cause the global oligonucleotide synthesis market to...
Clinical Trials
A Multi-Drug Trial On Cancer Precision Medicine Has Begun
A multi-drug, precision medicine trial involving Roche, the University of Manchester, and Cancer Research UK has begun for patients with rare cancers who need additional...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.